Pentacel

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaHaemophilus Influenzae Type bHepatitis BInfections, RotavirusPoliomyelitisTetanus

Phase 2

Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.

CompletedNCT00729001

GlaxoSmithKlineInfections, Rotavirus

Start: 2000-11-30End: 2002-09-30Updated: 2016-09-16

Phase 3

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

CompletedNCT02096263

GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +3

Start: 2014-04-16End: 2015-11-13Updated: 2019-11-27

Related Papers

Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and <i>Haemophilus influenzae</i> type b vaccine: a randomized trial in the United States

Human Vaccines & Immunotherapeutics2018-11-2016 citations

Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, <i>Rotarix</i>™: A retrospective laboratory analysis

Human Vaccines & Immunotherapeutics2016-09-228 citations